Concepedia

Luc Dasnois

LD

3

Publications

121

Citations

3

H-Index

2001

Active since

Affiliations

UCLouvain(Current)

Corixa Corporation

Luc Dasnois is an author at UCLouvain specializing in immunology, medicine, and drug discovery.

Top concepts

MedicineImmunologyPharmacologyDrug DiscoveryPharmacotherapyNatural SciencesCancer Cell BiologyMedicinal ChemistryOncologyPathology

Publications per year

2001–2006

3

Publications

3

<i>N</i>-Succinyl-(β-alanyl-<scp>l</scp>-leucyl-<scp>l</scp>-alanyl-<scp>l</scp>-leucyl)doxorubicin: An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Anne-Marie Fernandez, Kim Van derpoorten, Luc Dasnois et al. · Journal of Medicinal Chemistry · 2001 · 76 citations

Pharmaceutical Science, Intravenous Administration, Immunology +19

CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.

Vincent Dubois, Luc Dasnois, Karim Lebtahi et al. · PubMed · 2002 · 34 citations

Chemoprevention Strategy, Immunology, Heart Exposure +18

Thimet oligopeptidase (EC 3.4.24.15) activates CPI-0004Na, an extracellularly tumour-activated prodrug of doxorubicin

Vincent Dubois, Matthew Nieder, Françoise Collot et al. · European Journal of Cancer · 2006 · 11 citations

Medicinal Chemistry, Thimet Oligopeptidase, Extracellularly Tumour-activated Prodrug +9

Rows per page

1–3 of 3